Showing 161-170 of 2327 results for "".
The ABCDEs of AI for Skin Cancer Detection
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-abcdes-of-ai-for-skin-cancer-detection/23695/Key considerations for dermatologists as AI continues to expand.Grant Opportunity
https://practicaldermatology.com/topics/practice-management/grant-opportunity/21207/Native American Health Service Resident Rotation ProgramYour Destination for the Latest Developments in #Dermatology in Print and Online
https://practicaldermatology.com/topics/practice-management/your-destination-for-the-latest-developments-in-dermatology-in-print-and-online/21135/Psoriasis in Sensitive Areas
https://practicaldermatology.com/topics/psoriasis/psoriasis-in-sensitive-areas/23868/Treatment updates and tips for communicating with patients.Warfarin-Induced Nonuremic Calciphylaxis: A Case Study and Overview
https://practicaldermatology.com/youngmd-connect/resident-resource-center/warfarin-induced-nonuremic-calciphylaxis-a-case-study-and-overview/23872/A Definitive Guide to Recognizing and Treating “Maskne”
https://practicaldermatology.com/columns/clinical-focus-1/a-definitive-guide-to-recognizing-and-treating-maskne/23520/Practical Dermatology® magazine’s resident acne columnist offers step-by-step guidance.A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.Physician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/21039/The media is quick to use the phrase “game changer” whenever a new body-contouring device or technique enters the fray. An expert weighs in.Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.Teledermatology Use during the COVID-19 Pandemic
https://practicaldermatology.com/columns/clinical-focus-1/teledermatology-use-during-the-covid-19-pandemic/23769/Despite challenges, the future of teledermatology is promising.